CT-868
A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose
Carmot Therapeutics, Inc · Phase 1 · Completed · Enrollment 32
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| CT-868 | T2D only | n/r | n/r | n/r | n/r |
| Placebo | T2D only | n/r | n/r | n/r | n/r |
| Active Comparator | T2D only | n/r | n/r | n/r | n/r |